BioSpace News Archive

Chicagoans have recently noticed a new public health and safety message as they ride the “L.” The signage on several Chicago Transit Authority (CTA) trains and busses serving over 140 stations is sponsored by the Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin (MISSD).

Project management software innovator Moovila has been named among CIOReview’s 10 Most Promising Collaboration Solution Providers for 2018.

Reports Third-Quarter Diluted EPS of $1.81 on a GAAP Basis; Adjusted Diluted EPS of $2.14 Reflects Growth of 51.8 Percent

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that preliminary clinical and immunological data from its ongoing KEYNOTE-695 study, a global, multicenter, registration-directed Phase 2b trial of TAVO™ in combination with KEYTRUDA®

The FCS Foundation, the only patient group in the United States focused on supporting patients and families living with familial chylomicronemia syndrome (FCS), today recognizes the first-ever FCS Awareness Day,

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the appointment of Oved Amitay as Chief Business Officer.

Physician’s Computer Company (PCC), the leading Electronic Health Records (EHR) vendor for independent pediatricians nationwide, today announced the rollout of the WeCARE Program, a grant-based initiative aimed at supporting independent pediatric practices who see a high volume of underserved patients.

WGU Indiana will once again deliver Night Shift Nurse Appreciation Kits to hospitals and healthcare facilities throughout the state. The gesture thanks nurses who work an extra hour during their normal shift, due to the daylight savings time change on Nov. 4, 2018.

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, and RxCrossroads™ by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program to simplify the channel for precision medicine therapies.

Zynex announced today that it will host the Company’s 2018 third quarter investor webcast on Tuesday, November 6, 2018 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)